Could your pain be related to Rheumatoid Arthritis?
Learn about the signs and symptoms of Rheumatoid Arthritis and the options available for treatment.
Having trouble identifying pills? Try the Pill Identifier
Quickly identify pills, tablets and capsules using the web’s most comprehensive Pill Identification Wizard.
Worried about drug interactions? Use the Interactions Checker
The drug interactions tool allows you to check for drug-drug and drug-food interactions.
Discover treatment options with the new Symptom Checker
This interactive decision guide helps identify the underlying cause of common symptoms.
Custom search for Medical Transcriptionists?
Use our custom wildcard and phonetic search to assist in identifying drugs where the exact spelling is unknown and only the pronunciation is available.
Welcome to Drugs.com
Drugs.com is the most popular, comprehensive and up-to-date source of drug information online. Providing free, peer-reviewed, accurate and independent data on more than 24,000 prescription drugs, over-the-counter medicines & natural products. Find helpful tools, wallet size personal medication records, mobile applications and more.
- A to Z Drug List
- Drugs by Condition
- Pill Identifier
- Drug Side Effects
- Drug Dosage
- Interactions Checker
- News & Articles
- FDA Drug Alerts
- New Drug Approvals
- New Drug Applications
- Drug Imprint Codes
- International Drugs
- Drugs by Category
- Pregnancy Warnings
- Emergency Contraception
- Inactive Ingredients
- Video Center
- MedFacts Drug Information
- Cerner Multum Drug Information
- Micromedex Advanced Consumer
- MedFacts Natural Products
- FDA Professional Information
- A-Z Drug Facts (Facts & Comparisons)
- ASHP Monographs (AHFS DI)
- Micromedex Carenotes
- MedFacts Natural Products
Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following subarachnoid hemorrhage.
Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid/long-acting beta2 agonist (LABA) combination indicated for ...
Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption inhibitor combination ...
(Not yet approved)
Suvorexant is an orexin receptor antagonist in development for use in patients with difficulty falling or staying asleep.
Simeprevir is an investigational NS3/4A protease inhibitor in development for the treatment of chronic hepatitis C.
Tivozanib is an oral, once-daily, investigational tyrosine kinase inhibitor in development for the treatment of advanced renal cell ...
Daily Medical NewsRSS
FRIDAY, May 24 -- Patients hospitalized for heart failure appear to have better odds of survival if they're admitted on Mondays or in the morning, a new study finds. Death rates and length of stay are highest among heart failure patients admitted in January, on Fridays and overnight, according to the researchers, who are scheduled to present their findings Saturday in Portugal at the annual...
FRIDAY, May 24 -- Regular doses of the dietary supplement Coenzyme Q10 cut in half the death rate of patients suffering from advanced heart failure, in a randomized double-blind trial. Researchers also reported a significant decrease in the number of hospitalizations for heart failure patients being treated with Coenzyme Q10 (CoQ10). About 14 percent of patients taking the supplement suffered...
FRIDAY, May 24 -- New research suggests a link between sleep duration and suicidal thoughts among people with insomnia. Every additional hour someone with insomnia sleeps is associated with a 72 percent drop in the likelihood of moderate or high risk of suicide, according to researchers from the University of Pennsylvania. "We were surprised by the strength of the association between sleep...
Latest Pharma Industry NewsRSS
WHITEHOUSE STATION, N.J., May 22, 2013 -- Merck, known as MSD outside the United States and Canada, today provided the following statement after the conclusion of the Peripheral and Central Nervous System Drugs Advisory Committee meeting of the U.S. Food and Drug Administration (FDA) about suvorexant, Merck’s investigational medicine to treat insomnia. “We are excited about the potential...
May 15, 2013 -- The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for men whose cancer has spread after receiving medical or surgical therapy to lower testosterone. Prostate cancer forms in a gland in...
May 15, 2013 -- The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis. Simponi works by blocking tumor necrosis factor (TNF), which plays an important role in causing abnormal inflammatory and immune responses. Previously approved to treat rheumatoid arthritis, psoriatic arthritis and...
Latest Additions to Drugs.com
The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents ...
We are extremely proud to announce that Drugs.com has been nominated for the prestigious Webby Awards. Kudos to the hard working team! This is their fourth nomination in five years. To yet again be judged among the Internet’s top 5 health web sites is indeed an honor. But wait, there’s more… we need your vote! The ...
Today we are officially launching a new consumer tool to join other leading Drugs.com apps – the Drugs.com Medication Guide. Patients and caregivers will have instant access to their most recent personal medication records, the latest advice on drug therapy and medical conditions, and breaking health news tailored to their needs. In addition, consumers can ...